STOCK TITAN

Hims & Hers Insider Sales: 4,150 Shares Notice; Prior Sales ~$3.69M

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice by a holder of HIMS Class A shares reports a proposed sale and recent sales activity. The filer intends to sell 4,150 Class A shares through Fidelity Brokerage Services (NYSE) with an aggregate market value of $232,400 and an approximate sale date of 09/15/2025. The securities to be sold were acquired on 09/15/2025 by exercise of options granted on 08/10/2022, 02/24/2022 and 03/01/2023 (1,800; 2,100; and 250 shares respectively) with cash payment. The notice lists five Class A sales by Michael Y. Chi between 06/17/2025 and 08/01/2025 totaling 83,552 shares for gross proceeds of approximately $3,693,196.50. The signer represents no undisclosed material adverse information.

Positive

  • Transparent disclosure of proposed sale and prior sales, including acquisition dates and option origins
  • Certification that the seller does not possess undisclosed material adverse information, fulfilling Rule 144 attestation

Negative

  • Significant prior dispositions by the same person: five sales from 06/17/2025 to 08/01/2025 totaling approximately $3.69 million in gross proceeds
  • No 10b5-1 plan date provided, so reliance on an automatic trading plan is not documented in this notice

Insights

TL;DR: Insider exercises/options followed by multiple sales; proposed sale is modest relative to recent gross proceeds but warrants monitoring.

The filing documents option exercises and notification of a proposed sale of 4,150 Class A shares valued at $232,400. Recent reported dispositions by the same person total roughly $3.69 million in gross proceeds across five trades from June to August 2025, indicating active liquidity events rather than a single isolated transaction. This Form 144 is a routine compliance filing under Rule 144 confirming intent to sell and providing acquisition details; it does not itself disclose operational or financial performance metrics.

TL;DR: The filing reflects standard insider disclosure and a certification of no undisclosed material information; governance procedures appear followed.

The filer certified the absence of undisclosed material adverse information and provided acquisition and sale details, including that the shares to be sold arise from exercised options. The notice lacks any statement of a 10b5-1 plan adoption date, so no affirmative reliance on an affirmative defense is documented here. As presented, this is a procedural disclosure consistent with transparency obligations.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does HIMS Form 144 filed for ticker HIMS disclose?

The filing discloses a proposed sale of 4,150 Class A shares (aggregate market value $232,400) and prior sales totaling about $3,693,196.50.

Who is the seller listed in the HIMS Form 144?

Michael Y. Chi is listed as the seller for the prior transactions; the proposed sale lists Fidelity Brokerage Services as the broker.

When are the proposed sale and prior sales dated in this filing?

Proposed sale date: 09/15/2025. Prior sales dates: 06/17/2025, 07/23/2025, 07/24/2025, 07/31/2025, and 08/01/2025.

How were the securities being sold originally acquired according to the Form 144?

They were acquired by option exercises with option grant dates 08/10/2022, 02/24/2022 and 03/01/2023; payment method listed as cash.

Does the Form 144 state there is undisclosed material information?

No. The signer represents they do not know any material adverse information that has not been publicly disclosed.